Constitutive Activity of the Cannabinoid CB1 Receptor Regulates the Function of Co-expressed Mu Opioid Receptors*

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Biological Chemistry

• Publication date

  2008-04-25

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1074/jbc.M710300200PMID 18319252
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of a serotonin/glutamate receptor complex implicated in psychosis

  2008cited by this paper
• Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling.

  2008cited by this paper
• The Role of Diacylglycerol Lipase in Constitutive and Angiotensin AT1 Receptor-stimulated Cannabinoid CB1 Receptor Activity*

  2007cited by this paper
• Beta-arrestins and cell signaling.

  2007cited by this paper
• G protein-coupled receptor dimerisation: molecular basis and relevance to function.

  2007cited by this paper
• The evasive nature of drug efficacy: implications for drug discovery.

  2007cited by this paper
• β-Arrestins and Cell Signaling

  2007cited by this paper
• Versatility of GPCR recognition by drugs: from biological implications to therapeutic relevance.

  2007cited by this paper
• Protean Agonism at the Dopamine D2 Receptor: (S)-3-(3-Hydroxyphenyl)-N-propylpiperidine Is an Agonist for Activation of Go1 but an Antagonist/Inverse Agonist for Gi1,Gi2, and Gi3

  2007cited by this paper
• The α1b-Adrenoceptor Exists as a Higher-Order Oligomer: Effective Oligomerization Is Required for Receptor Maturation, Surface Delivery, and Function

  2007cited by this paper
• Inverse agonism: from curiosity to accepted dogma, but is it clinically relevant?

  2007cited by this paper
• An Essential Role for Constitutive Endocytosis, but Not Activity, in the Axonal Targeting of the CB1 Cannabinoid Receptor

  2007cited by this paper
• Extracellular Signal-Regulated Kinase 1/2-Mediated Transcriptional Regulation of G-Protein-Coupled Receptor Kinase 3 Expression in Neuronal Cells

  2007cited by this paper
• Up-regulation of the Angiotensin II Type 1 Receptor by the MAS Proto-oncogene Is Due to Constitutive Activation of Gq/G11 by MAS*

  2006cited by this paper
• Constitutive Activation Drives Compartment-Selective Endocytosis and Axonal Targeting of Type 1 Cannabinoid Receptors

  2006cited by this paper
• Orexin-1 Receptor-Cannabinoid CB1 Receptor Heterodimerization Results in Both Ligand-dependent and -independent Coordinated Alterations of Receptor Localization and Function*

  2006cited by this paper
• Distinct β-Arrestin- and G Protein-dependent Pathways for Parathyroid Hormone Receptor-stimulated ERK1/2 Activation*

  2006cited by this paper
• μ opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis

  2006cited by this paper
• Suppression of feeding, drinking, and locomotion by a putative cannabinoid receptor 'silent antagonist'.

  2006cited by this paper
• Interactions between the Mas-Related Receptors MrgD and MrgE Alter Signalling and Trafficking of MrgD

  2006cited by this paper
• Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core.

  2006cited by this paper
• Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse.

  2006cited by this paper
• Virus-encoded G-protein-coupled receptors: constitutively active (dys)regulators of cell function and their potential as drug target.

  2006cited by this paper
• Opioid and cannabinoid receptors: friends with benefits or just close friends?

  2006cited by this paper
• Mu Opioid Receptor Activation of ERK1/2 Is GRK3 and Arrestin Dependent in Striatal Neurons*

  2006cited by this paper
• G-protein-coupled receptor heterodimers: pharmacology, function and relevance to drug discovery.

  2006cited by this paper
• Inverse agonism and neutral antagonism at cannabinoid CB1 receptors.

  2005cited by this paper
• Cannabinoid receptor signaling.

  2005cited by this paper
• Motivational Effects of Cannabinoids and Opioids on Food Reinforcement Depend on Simultaneous Activation of Cannabinoid and Opioid Systems

  2005cited by this paper
• Concurrent Stimulation of Cannabinoid CB1 and Dopamine D2 Receptors Enhances Heterodimer Formation: A Mechanism for Receptor Cross-Talk?

  2005cited by this paper
• Assay of G Protein-Coupled Receptor Activation of G Proteins in Native Cell Membranes Using [ 35 S]GTPγS Binding

  2004cited by this paper
• Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens.

  2004cited by this paper
• Assay of G protein-coupled receptor activation of G proteins in native cell membranes using [35S]GTP gamma S binding.

  2004cited by this paper
• Opioid receptors.

  2004cited by this paper
• Efficacy as a vector: the relative prevalence and paucity of inverse agonism.

  2004cited by this paper
• Differential Kinetic and Spatial Patterns of β-Arrestin and G Protein-mediated ERK Activation by the Angiotensin II Receptor*

  2004cited by this paper
• Hypersensitization of the Orexin 1 Receptor by the CB1 Receptor

  2003cited by this paper
• Principles: extending the utility of [35S]GTP gamma S binding assays.

  2003cited by this paper
• Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective.

  2003cited by this paper
• GPCR dimerisation.

  2003cited by this paper
• Endocytosis of the Viral Chemokine Receptor US28 Does Not Require Beta‐Arrestins But Is Dependent on the Clathrin‐Mediated Pathway

  2002cited by this paper
• G protein-coupled receptor signalling and cross-talk: achieving rapidity and specificity.

  2002cited by this paper
• New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades

  2001cited by this paper
• Virally encoded 7TM receptors

  2001cited by this paper
• Functional Interaction between Opioid and Cannabinoid Receptors in Drug Self-Administration

  2001cited by this paper
• Ultrastructural Localization of the CB1 Cannabinoid Receptor in μ-Opioid Receptor Patches of the Rat Caudate Putamen Nucleus

  2001cited by this paper
• CB1-cannabinoid and μ-opioid receptor co-localization on postsynaptic target in the rat dorsal horn

  2001cited by this paper
• Structural Domains of the CB1 Cannabinoid Receptor That Contribute to Constitutive Activity and G-Protein Sequestration

  2001cited by this paper
• Involvement of the Carboxyl Terminus of the Third Intracellular Loop of the Cannabinoid CB1 Receptor in Constitutive Activation of Gs

  1999cited by this paper
• A mutation in the second transmembrane region of the CB1 receptor selectively disrupts G protein signaling and prevents receptor internalization.

  1999cited by this paper
• G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways.

  1998cited by this paper
• Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors

  1998cited by this paper
• Mutation of a highly conserved aspartate residue in the second transmembrane domain of the cannabinoid receptors, CB1 and CB2, disrupts G-protein coupling.

  1998cited by this paper
• Concurrent Stimulation of Cannabinoid CB1 and Dopamine D2 Receptors Augments cAMP Accumulation in Striatal Neurons: Evidence for a Gs Linkage to the CB1 Receptor

  1997cited by this paper
• Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.

  1997cited by this paper
• Regulation of Spontaneous Activity of the δ‐Opioid Receptor: Studies of Inverse Agonism in Intact Cells

  1997cited by this paper
• Molecular Mechanisms of Opiate Receptor Coupling to G Proteins and Effector Systems a

  1996cited by this paper
• Agonist activation of p42 and p44 mitogen-activated protein kinases following expression of the mouse delta opioid receptor in Rat-1 fibroblasts: effects of receptor expression levels and comparisons with G-protein activation.

  1996cited by this paper
• Pharmacology of cannabinoid receptors.

  1995cited by this paper
• [21] Specificity and functional applications of antipeptide antisera which identify G-protein α subunits

  1994cited by this paper
• Enhanced degradation of the phosphoinositidase C-linked guanine-nucleotide-binding protein Gq alpha/G11 alpha following activation of the human M1 muscarinic acetylcholine receptor expressed in CHO cells.

  1993cited by this paper
• Opioid and Cannabinoid Receptor Inhibition of Adenylyl Cyclase in Brain a

  1992cited by this paper
• Concurrent down-regulation of IP prostanoid receptors and the alpha-subunit of the stimulatory guanine-nucleotide-binding protein (Gs) during prolonged exposure of neuroblastoma x glioma cells to prostanoid agonists. Quantification and functional implications.

  1992cited by this paper
• Identification of Two Distinct Isoforms of the Guanine Nucleotide Binding Protein Go in Neuroblastoma × Glioma Hybrid Cells: Independent Regulation During Cyclic AMP‐Induced Differentiation

  1990cited by this paper

• Constitutive activation and allosteric mechanisms underlying Gi/Gq signaling bias in SUCNR1 revealed by AlphaFold-based modeling and enhanced sampling simulations

  2025cites this paper
• Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders

  2024cites this paper
• SGIP1 in axons prevents internalization of desensitized CB1R and modifies its function

  2023cites this paper
• Comparison and interaction of morphine and CB1 agonist conditioned place preference in the rat model of early life stress

  2021cites this paper
• Noncanonical Activity of Endocannabinoids and Their Receptors in Central and Peripheral Synapses

  2021cites this paper
• SGIP1 is involved in regulation of emotionality, mood, and nociception and modulates in vivo signalling of cannabinoid CB1 receptors

  2021cites this paper
• Quantitative assessment of constitutive G protein-coupled receptor activity with BRET-based G protein biosensors

  2021cites this paper
• Structural basis for the constitutive activity and immunomodulatory properties of the Epstein-Barr virus-encoded G protein-coupled receptor BILF1.

  2021cites this paper
• New perspectives on the role of the neurosteroid pregnenolone as an endogenous regulator of type‐1 cannabinoid receptor (CB1R) activity and function

  2021cites this paper
• Alpha technology: a powerful tool to detect mouse brain intracellular signaling events.

  2019cites this paper
• Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo

  2018cites this paper
• Allosteric Modulation of the Cannabinoid CB1 Receptor

  2017cites this paper
• Class A GPCRs: Cannabinoid and Opioid Receptor Heteromers

  2017cites this paper
• Somatostatin receptor 5 is a prominent regulator of signaling pathways in cells with coexpression of Cannabinoid receptors 1.

  2017influential citation
• Characterisation of Melanocortin 4 Receptor Constitutive Activity: Signalling by Signature

  2017cites this paper
• M3 muscarinic acetylcholine receptor facilitates the endocytosis of mu opioid receptor mediated by morphine independently of the formation of heteromeric complexes.

  2017cites this paper
• Cannabis: A Treasure Trove or Pandora's Box?

  2017cites this paper
• Sulfation of the FLAG epitope is affected by co-expression of G protein-coupled receptors in a mammalian cell model

  2016cites this paper
• Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl.

  2016cites this paper
• Cannabinoids and Cytochrome P450 Interactions.

  2016cites this paper
• Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex

  2016cites this paper
• Involvement of opioid system in antidepressant‐like effect of the cannabinoid CB1 receptor inverse agonist AM‐251 after physical stress in mice

  2016cites this paper
• The effects of endocannabinoid receptor agonist anandamide and antagonist rimonabant on opioid analgesia and tolerance in rats.

  2015cites this paper
• Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor

  2015influential citation
• Cannabinoid-Opioid Interactions

  2015cites this paper
• RETRACTED ARTICLE: Functionalized benzyls as selective κ-OR agonists

  2015cites this paper
• The cannabinoid system and impulsive behavior

  2015cites this paper
• Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity

  2015cites this paper
• Rôle et implication du système cannabinoïde dans la modulation périphérique de la douleur inflammatoire et neuropathique

  2014cites this paper
• Involvement of cannabinoid receptors in peripheral and spinal morphine analgesia.

  2014cites this paper
• Rimonabant: a CB1 receptor antagonist as a direct interactional partner for μ- and δ-opioid receptor

  2014cites this paper
• The vital role of constitutive GPCR activity in the mesolimbic dopamine system

  2014cites this paper
• Properties of 4 Hz stimulation‐induced parallel fiber–Purkinje cell presynaptic long‐term plasticity in mouse cerebellar cortex in vivo

  2014influential citation
• Trajectory of adolescent cannabis use on addiction vulnerability.

  2014cites this paper
• O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus

  2014influential citation
• Neutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity

  2013cites this paper
• Nucleus accumbens and food intake 1 CB 1 receptors modulate the intake of a sweetened fat diet in response to mu-opioid receptor stimulation of the nucleus accumbens

  2013cites this paper
• Delineation of Domains Within the Cannabinoid CB1 and Dopamine D2 Receptors That Mediate the Formation of the Heterodimer Complex

  2013cites this paper
• Chronic Effects of Cannabinoid Drugs on Monoaminergic Systems and the Role of Endocannabinoids and Cannabinoid Receptors in Human Brain Disorders

  2013cites this paper
• Ventral tegmental area cannabinoid type-1 receptors control voluntary exercise performance.

  2013cites this paper
• The Prevalence, Maintenance, and Relevance of G Protein–Coupled Receptor Oligomerization

  2013cites this paper
• The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: evidence from postmortem human brain.

  2012cites this paper
• Effects induced by cannabinoids on monoaminergic systems in the brain and their implications for psychiatric disorders.

  2012cites this paper
• Reports of the death of CB1 antagonists have been greatly exaggerated: recent preclinical findings predict improved safety in the treatment of obesity

  2012cites this paper
• AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies.

  2012influential citation
• Inhibition of forebrain l-opioid receptor signaling by low concentrations of rimonabant does not require cannabinoid receptors and directly involves l-opioid receptors

  2012cites this paper
• Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism.

  2012cites this paper
• Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades.

  2012cites this paper
• CB1‐independent mechanisms of Δ9‐THCV, AM251 and SR141716 (rimonabant)

  2012cites this paper
• Ligand‐induced internalization of the orexin OX1 and cannabinoid CB1 receptors assessed via N‐terminal SNAP and CLIP‐tagging

  2011cites this paper
• Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk

  2011cites this paper
• Inducible expression of G protein-coupled receptors in transfected cells.

  2011cites this paper
• Human δ opioid receptor Phe27 and Cys27 variants : the role of heteromerization and pharmacological chaperones in receptor processing and trafficking

  2011cites this paper
• Cannabinoid CB1 Receptor Activation Mediates the Opposing Effects of Amphetamine on Impulsive Action and Impulsive Choice

  2011cites this paper
• Heteromultimerization of Cannabinoid CB1 Receptor and Orexin OX1 Receptor Generates a Unique Complex in Which Both Protomers Are Regulated by Orexin A*

  2011cites this paper
• G protein‐coupled receptors: walking hand‐in‐hand, talking hand‐in‐hand?

  2011cites this paper
• Agonist activation of the G protein‐coupled receptor GPR35 involves transmembrane domain III and is transduced via Gα13 and β‐arrestin‐2

  2011cites this paper
• Endocannabinoid tone versus constitutive activity of cannabinoid receptors

  2011cites this paper
• Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?

  2011cites this paper
• Physical and functional interaction between CB1 cannabinoid receptors and β2‐adrenoceptors

  2010cites this paper
• Constitutive activity at the cannabinoid CB(1) receptor and behavioral responses.

  2010cites this paper
• Constitutive activity of GPR40/FFA1 intrinsic or assay dependent?

  2010cites this paper
• Allostery at G Protein-Coupled Receptor Homo- and Heteromers: Uncharted Pharmacological Landscapes

  2010cites this paper
• THEMED ISSUE: CANNABINOIDS RESEARCH PAPER Regulation of Fas receptor/Fas-asssociated protein with death domain apoptotic complex and associated signalling systems by cannabinoid receptors in the mouse brain

  2010cites this paper
• The Epstein-Barr Virus-encoded G Protein-coupled Receptor BILF1 Hetero-oligomerizes with Human CXCR4, Scavenges Gαi Proteins, and Constitutively Impairs CXCR4 Functioning*

  2010cites this paper
• International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

  2010influential citation
• Functional interactions between endogenous cannabinoid and opioid systems: focus on alcohol, genetics and drug-addicted behaviors.

  2010cites this paper
• Signal transduction of the CB 1 cannabinoid receptor

  2010influential citation
• CB1 receptors modulate the intake of a sweetened-fat diet in response to μ-opioid receptor stimulation of the nucleus accumbens.

  2010influential citation
• Agonist-dependent mu-opioid receptor signaling can lead to heterologous desensitization.

  2010cites this paper
• Signal transduction of the CB1 cannabinoid receptor.

  2010influential citation
• The Action and Mode of Binding of Thiazolidinedione Ligands at Free Fatty Acid Receptor 1*♦

  2009cites this paper
• Selectivity and functional consequences of interactions of family A G protein‐coupled receptors with neurochondrin and periplakin

  2009cites this paper
• CB1 Receptor-Independent Actions of SR141716 on G-Protein Signaling: Coapplication with the μ-Opioid Agonist Tyr-d-Ala-Gly-(NMe)Phe-Gly-ol Unmasks Novel, Pertussis Toxin-Insensitive Opioid Signaling in μ-Opioid Receptor-Chinese Hamster Ovary Cells

  2009cites this paper
• CB1 Receptors Mediate the Analgesic Effects of Cannabinoids on Colorectal Distension-Induced Visceral Pain in Rodents

  2009cites this paper
• Presynaptically expressed long-term depression at cerebellar parallel fiber synapses

  2009cites this paper
• Signal transduction via cannabinoid receptors.

  2009cites this paper
• Endogenous opiates and behavior: 2008.

  2009cites this paper
• Endocannabinoid receptor pharmacology.

  2009cites this paper
• Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis.

  2009cites this paper
• Pharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: Drug-discovery strategies

  2009cites this paper
• New Directions in Receptor Research; Receptor Selectivity and Promiscuity

  2009cites this paper
• Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis

  2009cites this paper
• Functional Selectivity at Receptors for Cannabinoids and Other Lipids

  2009cites this paper
• Agonist-dependent mechanism of mu-opioid receptor desensitization

  2009cites this paper
• Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.

  2008cites this paper
• Molecular and structural effects of inverse agonistic mutations on signaling of the thyrotropin receptor – a basally active GPCR

  2008cites this paper
• Conserved Polar Residues in Transmembrane Domains V, VI, and VII of Free Fatty Acid Receptor 2 and Free Fatty Acid Receptor 3 Are Required for the Binding and Function of Short Chain Fatty Acids*

  2008cites this paper
• Combining building thermal simulation methods and LCA methods

  2008cites this paper
• Morphine Desensitization, Internalization, and Down-Regulation of the μ Opioid Receptor Is Facilitated by Serotonin 5-Hydroxytryptamine2A Receptor Coactivation

  2008cites this paper